EXACOMPTA CLAIREFONTAINE (EPA:EXAC) | WebDisclosure

Basculer en Français

10443	Companies
219242	Keywords
148699	Articles
115971	Press releases

Headlines Articles Press releases EXACOMPTA CLAIREFONTAINE

Home
Companies
EXACOMPTA CLAIREFONTAINE

REGULATED PRESS RELEASE

published on 09/24/2025 at 18:15, 7 months 28 days ago

Rapport semestriel 2025
BRIEF

published on 09/23/2025 at 18:20, 7 months 29 days ago

EXACOMPTA CLAIREFONTAINE Reports Decrease in H1 2025 Profits

Financial Results Market Challenges Revenue Decline Operating Income Management Changes
BRIEF

published on 09/23/2025 at 18:20, 7 months 29 days ago

EXACOMPTA CLAIREFONTAINE annonce une baisse de ses bénéfices au premier semestre 2025

Résultats Financiers Baisse Des Revenus Défis Du Marché Changements De Direction Résultat D'exploitation
REGULATED PRESS RELEASE

published on 09/23/2025 at 18:15, 7 months 29 days ago

Financial statements - 30 june 2025
EXACOMPTA CLAIREFONTAINE Board of Directors reviewed and approved Group financial statements for H1 2025 in Paris. Revenue down, operating income dropped, economic challenges noted

Financial Statements Revenue Operating Income Exacompta Clairefontaine Economic Conditions
BRIEF

published on 09/18/2025 at 18:20, 8 months 4 days ago

EXACOMPTA CLAIREFONTAINE 2025 half-year report: declining results

Half-year Results Turnover General Management Financial Debt Outlook 2025
BRIEF

published on 09/18/2025 at 18:20, 8 months 4 days ago

Bilan semestriel 2025 d'EXACOMPTA CLAIREFONTAINE : résultats en baisse

Chiffre D'affaires Résultats Semestriels Direction Générale Endettement Financier Perspectives 2025
REGULATED PRESS RELEASE

published on 09/18/2025 at 18:15, 8 months 4 days ago

Rapport semestriel 2025
Le conseil d'administration d'EXACOMPTA CLAIREFONTAINE arrête les comptes du 1er semestre 2025, marquant une baisse des résultats. Changement majeur aux postes de direction

Conseil D'administration Baisse Direction Exacompta Clairefontaine Comptes
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:11, 1 year ago

DPEF - non financial performance declaration 2024
REGULATED PRESS RELEASE

published on 05/13/2025 at 18:10, 1 year ago

Annual report 2024
REGULATED PRESS RELEASE

published on 04/28/2025 at 18:10, 1 year ago

Rapport annuel 2024 - DPEF

Accesswire

Published on 05/23/2026 at 03:15, 14 hours 14 minutes ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 14 hours 29 minutes ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 15 hours 4 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 15 hours 4 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 16 hours 29 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

View all ACCESSWIRE

EQS Group

Published on 05/23/2026 at 16:30, 59 minutes ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 1 hour 32 minutes ago

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 19 hours 24 minutes ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 19 hours 24 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 21 hours 38 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices

Les Echos

Published on 05/22/2026 at 19:35, 21 hours 54 minutes ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 23 hours 24 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 23 hours 24 minutes ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 4 hours ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 4 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE